# Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

> **NCT02316548** · PHASE2 · TERMINATED · sponsor: **NRG Oncology** · enrollment: 14 (actual)

## Conditions studied

- Stage III Bladder Cancer
- Stage IV Bladder Cancer

## Interventions

- **RADIATION:** Intensity-Modulated Radiation Therapy

## Key facts

- **NCT ID:** NCT02316548
- **Lead sponsor:** NRG Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2017-02-01
- **Final completion:** 2017-02-01
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Trial will not meet CTEP Early Phase Trial Slow Accrual Guidelines
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02316548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02316548, "Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02316548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*